Gene · 80339
Papers3,957
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
821 to 840 of 3,957
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Characteristics and long-term mortality of patients with non-MAFLD hepatic steatosis. | Hepatol Int | 2023 | 37000387 | PubTator, text mining | PubMed |
| Hepatic stellate cell activation markers are regulated by the vagus nerve in systemic inflammation. | Bioelectron Med | 2023 | 36997988 | PubTator, text mining | PubMed |
| Non-Alcoholic Fatty Liver Disease and Vitamin D in the UK Biobank: A Two-Sample Bidirectional Mendelian Randomisation Study. | Nutrients | 2023 | 36986172 | PubTator, text mining | PubMed |
| Small Intestinal Bacterial Overgrowth and Non-Alcoholic Fatty Liver Disease: What Do We Know in 2023? | Nutrients | 2023 | 36986052 | PubTator, text mining | PubMed |
| Baseline Tyrosine Level Is Associated with Dynamic Changes in FAST Score in NAFLD Patients under Lifestyle Modification. | Metabolites | 2023 | 36984884 | PubTator, text mining | PubMed |
| Epigenetic Modifications Induced by the Gut Microbiota May Result from What We Eat: Should We Talk about Precision Diet in Health and Disease? | Metabolites | 2023 | 36984815 | PubTator, text mining | PubMed |
| Metabolic-Dysfunction-Associated Fatty Liver Disease and Gut Microbiota: From Fatty Liver to Dysmetabolic Syndrome. | Medicina (Kaunas) | 2023 | 36984595 | PubTator, text mining | PubMed |
| Genetic Variants Determine Treatment Response in Autoimmune Hepatitis. | J Pers Med | 2023 | 36983720 | PubTator, text mining | PubMed |
| Comparison of MAFLD and NAFLD Characteristics in Children. | Children (Basel) | 2023 | 36980118 | PubTator, text mining | PubMed |
| Metabolic dysfunction-associated fatty liver disease (MAFLD): an update of the recent advances in pharmacological treatment. | J Physiol Biochem | 2023 | 36976456 | PubTator, text mining | PubMed |
| Unprocessed Red Meat and Processed Meat Consumption, Plasma Metabolome, and Risk of Ischemic Heart Disease: A Prospective Cohort Study of UK Biobank. | J Am Heart Assoc | 2023 | 36974753 | PubTator, text mining | PubMed |
| Correlation between nonalcoholic fatty liver disease and left ventricular diastolic dysfunction in non-obese adults: a cross-sectional study. | BMC Gastroenterol | 2023 | 36973654 | PubTator, text mining | PubMed |
| Clustering NAFLD: phenotypes of nonalcoholic fatty liver disease and their differing trajectories. | Hepatol Commun | 2023 | 36972374 | PubTator, text mining | PubMed |
| Fatty liver disease in children (MAFLD/PeFLD Type 2): unique classification considerations and challenges. | Ther Adv Endocrinol Metab | 2023 | 36968656 | PubTator, text mining | PubMed |
| Gene variations related to the hepatocellular carcinoma: Results from a field synopsis and Bayesian revaluation. | Gene | 2023 | 36966980 | PubTator, text mining | PubMed |
| Integrative transcriptomic and metabolomic analysis reveals alterations in energy metabolism and mitochondrial functionality in broiler chickens with wooden breast. | Sci Rep | 2023 | 36959331 | PubTator, text mining | PubMed |
| Adverse effect of PNPLA3 p.I148M genetic variant on kidney function in middle-aged individuals with metabolic dysfunction. | Aliment Pharmacol Ther | 2023 | 36947711 | PubTator, text mining | PubMed |
| PNPLA3 rs738409 risk genotype decouples TyG index from HOMA2-IR and intrahepatic lipid content. | Cardiovasc Diabetol | 2023 | 36944955 | PubTator, text mining | PubMed |
| Performance of Non-invasive Biomarkers of Liver Fibrosis Amongst Hispanics and African Americans. | Cureus | 2023 | 36938211 | PubTator, text mining | PubMed |
| Genomic analysis of lean individuals with NAFLD identifies monogenic disorders in a prospective cohort study. | JHEP Rep | 2023 | 36937991 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/80339/papers?page=42